Goodpath, a virtual provider for chronic conditions, has raised $18 million in Series A funding, which it is using to expand its reach and accelerate development of AI, the company announced Thursday.
When people battle a chronic condition, they often have several other health conditions associated with that issue. For example, those who have back pain may also be dealing with poor sleep or stress and anxiety.
Boston-based Goodpath addresses this by treating multiple conditions under one platform, including musculoskeletal conditions, weight management, diabetes, digestive health, sleep, mental health and cancer survivorship. The company, which serves employers, offers multidisciplinary care, meaning a collaborative approach in which providers of different specialties work together to treat the patient. It leverages AI to create a personalized care plan. It also provides a dedicated health coach, talk therapy and digital resources like exercise videos and educational materials.
“We tackle the problem of fragmentation,” said Bill Gianoukos, CEO and cofounder of Goodpath, in an email. “Too many patients bounce between disconnected point solutions or specialists that only treat one part of their health. We took the integrative care model that is traditionally only available to high-net-worth individuals, and made it affordable and scalable using technology and AI.”
Goodpath’s Series A round was led by MassMutual Ventures and included participation from Healthy Ventures. In total, the company has raised $22 million.
“Chronic and mental health conditions account for the vast majority of U.S. healthcare costs, and yet the way care is delivered has lagged behind. We believe the next generation of category leaders will be those that deliver this combination of scale, precision, and measurable cost impact in a single model,” said Eric Emmons, managing partner at MassMutual Ventures, in a statement. “What excites us about Goodpath is that it is already demonstrating that combination: high engagement across large populations, predictive use of data and outcomes that show up directly in claims.”
The financing will be used to expand into new condition categories and advance its AI engine, “specifically advancing our AI-driven personalization to create even more dynamic care programs tailored to each member’s unique health history, behaviors, and needs,” Gianoukos said. In addition, Goodpath is investing in its pharmacy infrastructure to provide access to GLP-1s.
Currently, chronic condition care is extremely fragmented. Those who battle mental health conditions, musculoskeletal conditions or cancer often have to see multiple specialists who aren’t connected with one another, leading to higher costs for patients and employers. That’s what Goodpath ultimately hopes to solve.
“Our goal is to make Goodpath the standard model for chronic condition management, and increasing access to integrative care so that anyone can access this quality of medicine,” Gianoukos said. “We’re actively expanding into payer partnerships to expand on what we’ve done for large employers. Long term, we want every payer in the country to recognize Goodpath as an approved, effective, and cost-saving treatment pathway.”
Photo: TAW4, Getty Images
